Ignite Creation Date:
2024-05-05 @ 10:17 PM
Last Modification Date:
2024-10-26 @ 10:17 AM
Study NCT ID:
NCT01078662
Status:
COMPLETED
Last Update Posted:
2024-06-20
First Post:
2010-03-01
Brief Title:
Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-02-21
Start Date Type:
ACTUAL
Primary Completion Date:
2012-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2010-03-01
First Submit QC Date:
March 1 2010
Study First Post Date:
2010-03-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2015-05-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2013-05-09
Disp First Submit QC Date:
May 9 2013
Disp First Post Date:
2013-05-16
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2024-09-18
Last Update Post Date:
2024-06-20
Last Update Post Date Type:
ACTUAL